Testing a noninvasive way to collect pancreatic cells early
Part of Cancer clinical trials.
This study tests LINFU™, a noninvasive method to collect pancreatic cells to help detect pancreatic cancer earlier. You may be invited if you’re at higher risk or you have concerning symptoms and planned pancreas/bile testing (like EUS or CT).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between ages 18 and 89
- You’re being checked because you’re at higher risk for pancreatic cancer or you have symptoms/imaging that look concerning
- You must be able to sign consent approved by the study team’s review board
- You are not pregnant, and you don’t have a pregnancy risk that makes you ineligible
- You should be able to safely undergo the planned procedure(s) (like EUS/ERCP) without unsafe bleeding risk, serious anesthesia problems, or an unstable health condition
- You can’t have an allergy to the microbubble contrast dye or secretin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at healthy adults who have no symptoms or risk factors for pancreatic cancer to test a new imaging method that may help find early signs of the disease. If you join, you will have an endoscopic ultrasound (a thin tube with a camera passed to your stomach) to check your pancreas.
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
This study is looking at genetic material and proteins from pancreatic tumors to understand how the cancer responds to treatment. It aims to help doctors choose the best therapies for patients with certain types of pancreatic cancer that can be removed surgically or that have not spread to other organs.
This study is testing a new imaging method called LINFU® to see if it can find pancreatic cancer early in people who are at higher risk but have no symptoms. If you are at elevated risk for pancreatic cancer and are already getting imaging tests, this study may help improve early detection.
This study is collecting information from people who may have pancreatic cancer to see how a new ultrasound imaging technique (called LINFU) works for helping doctors decide whether a biopsy is needed. Participation could provide better imaging to guide your care.
This study follows patients with a type of pancreatic cyst called IPMN who receive the LINFU procedure, a treatment that uses sound waves and microbubbles. Researchers want to see how well it works and monitor safety.
Hear when a new Pancreatic Ductal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.